DrugPatentWatch Database Preview
Litigation Details for GENENTECH, INC. v. SANDOZ, INC. (D.N.J. 2017)
» See Plans and Pricing
GENENTECH, INC. v. SANDOZ, INC. (D.N.J. 2017)
| Docket | Start Trial | Date Filed | 2017-12-21 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 15:1126 Patent Infringement | Assigned To | Renee Marie Bumb |
| Jury Demand | Both | Referred To | Karen M. Williams |
| Parties | BIOGEN, INC.; CITY OF HOPE; GENENTECH, INC.; SANDOZ GMBH; SANDOZ INTERNATIONAL GMBH; SANDOZ, INC. | ||
| Patents | 7,381,560; 7,485,704; 7,807,799; 7,820,161; 7,976,838; 8,206,711; 8,329,172; 8,512,983; 8,545,843; 8,557,244; 8,821,873; 9,296,821; 9,504,744; 9,714,293 | ||
| Attorneys | KEITH J. MILLER; LISA J. RODRIGUEZ; MICHAEL JAMES GESUALDO | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in GENENTECH, INC. v. SANDOZ, INC.
The biologic drugs covered by the patents cited in this case are Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , and Start Trial .
Details for GENENTECH, INC. v. SANDOZ, INC. (D.N.J. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-12-21 | 1 | U.S. Patent No. 7,381,560 81. U.S. Patent No. 7,381,560 (“the ’560 patent”) is entitled… COUNT VII (INFRINGEMENT OF U.S. PATENT NO. 7,381,560 UNDER 35 U.S.C. § 271(E)(2)) …DECLARATORY JUDGMENT OF INFRINGEMENT OF U.S. PATENT NO. 7,381,560) 540. Plaintiffs re-allege… U.S. Patent No. 6,121,428 69. U.S. Patent No. 6,121,428 (“the ’428 patent”) is entitled… U.S. Patent No. 6,331,415 71. U.S. Patent No. 6,331,415 (“the ’415 patent”) is entitled | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
